These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
414 related items for PubMed ID: 19207164
1. Recommendations of the ISBT Working Party on Granulocyte Immunobiology for leucocyte antibody screening in the investigation and prevention of antibody-mediated transfusion-related acute lung injury. ISBT Working Party on Granulocyte ImmunobiologyPlatelet and Leucocyte Immunology Laboratory, EFS Ile de France, Hopital Henri Mondor, Creteil, France., Bierling P, Bux J, Curtis B, Flesch B, Fung L, Lucas G, Macek M, Muniz-Diaz E, Porcelijn L, Reil A, Sachs U, Schuller R, Tsuno N, Uhrynowska M, Urbaniak S, Valentin N, Wikman A, Zupanska B. Vox Sang; 2009 Apr; 96(3):266-9. PubMed ID: 19207164 [Abstract] [Full Text] [Related]
3. Screening of multiparous women to avoid transfusion-related acute lung injury: a single centre experience. Sachs UJ, Link E, Hofmann C, Wasel W, Bein G. Transfus Med; 2008 Dec; 18(6):348-54. PubMed ID: 19140817 [Abstract] [Full Text] [Related]
4. Frequency and severity of transfusion-related acute lung injury--German haemovigilance data (2006-2007). Keller-Stanislawski B, Reil A, Günay S, Funk MB. Vox Sang; 2010 Jan; 98(1):70-7. PubMed ID: 19671122 [Abstract] [Full Text] [Related]
5. Transfusion-related acute lung injury and leucocyte-reacting antibodies. Zupanska B, Uhrynowska M, Michur H, Maslanka K, Zajko M. Vox Sang; 2007 Jul; 93(1):70-7. PubMed ID: 17547568 [Abstract] [Full Text] [Related]
6. Allo-exposure status and leucocyte antibody positivity of blood donors show a similar relation with TRALI. Middelburg RA, Beckers EA, Porcelijn L, Lardy N, Wiersum-Osselton JC, Schipperus MR, Vrielink H, Briët E, van der Bom JG. Transfus Med; 2012 Apr; 22(2):128-32. PubMed ID: 22380759 [Abstract] [Full Text] [Related]
8. Testing only donors with a prior history of pregnancy or transfusion is a logical and cost-effective transfusion-related acute lung injury prevention strategy. Powers A, Stowell CP, Dzik WH, Saidman SL, Lee H, Makar RS. Transfusion; 2008 Dec; 48(12):2549-58. PubMed ID: 18717778 [Abstract] [Full Text] [Related]
9. TRALI risk reduction: donor and component management strategies. Eder AF, Benjamin RJ. J Clin Apher; 2009 Dec; 24(3):122-9. PubMed ID: 19365816 [Abstract] [Full Text] [Related]
12. How much residual plasma may cause TRALI? Win N, Chapman CE, Bowles KM, Green A, Bradley S, Edmondson D, Wallis JP. Transfus Med; 2008 Oct; 18(5):276-80. PubMed ID: 18937733 [Abstract] [Full Text] [Related]
16. Implementation and outcomes of a transfusion-related acute lung injury surveillance programme and study of HLA/HNA alloimmunisation in blood donors. Porretti L, Cattaneo A, Coluccio E, Mantione E, Colombo F, Mariani M, Bottelli G, Mazzucchelli S, Pappalettera M, Speranza T, Migliari M, Cambié G, Prati D, Rebulla P. Blood Transfus; 2012 Jul; 10(3):351-9. PubMed ID: 22395353 [Abstract] [Full Text] [Related]
17. Anti-leucocyte antibodies in platelet apheresis donors with and without prior immunizing events: implications for TRALI prevention. Sigle JP, Thierbach J, Infanti L, Muriset M, Hunziker G, Chassot K, Niederhauser C, Gowland P, Holbro A, Sunic K, Buser A, Fontana S. Vox Sang; 2013 Oct; 105(3):244-52. PubMed ID: 23773018 [Abstract] [Full Text] [Related]
18. Reducing the incidence of TRALI in the UK: the results of screening for donor leucocyte antibodies and the development of national guidelines. Lucas G, Win N, Calvert A, Green A, Griffin E, Bendukidze N, Hopkins M, Browne T, Poles A, Chapman C, Massey E. Vox Sang; 2012 Jul; 103(1):10-7. PubMed ID: 22150747 [Abstract] [Full Text] [Related]